Abiopharma

Aptose Presents Safety, Response, and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2026 EHA Congress in Oral Presentation

Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome

Plains All American Pipeline and Plains GP Holdings Provide Updated Capital Spending Guidance for 2026

Aramark Student Nutrition Announces Nationwide Update to School Menus for 2026–2027

Immuneering Appoints Andrew Gengos as Chief Financial Officer

Jack in the Box Inc. Prices $500 Million Securitized Financing Facility

Safehold Declares Second Quarter 2026 Common Stock Dividend

Dragonfly Energy Receives European Patent Allowance for Advancing Dry Electrode and Solid-State Battery Manufacturing

10 Barrel Brewing and Pub Beer Kick Off Pacific Northwest Summer of Soccer Celebration

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company